List of Tables
    Table 1. Anti-spasmodic Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Anti-spasmodic Drugs Market Trends
    Table 3. Anti-spasmodic Drugs Market Drivers
    Table 4. Anti-spasmodic Drugs Market Challenges
    Table 5. Anti-spasmodic Drugs Market Restraints
    Table 6. Global Anti-spasmodic Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti-spasmodic Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti-spasmodic Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti-spasmodic Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti-spasmodic Drugs Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti-spasmodic Drugs Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Anti-spasmodic Drugs Revenue Share by Player, 2017-2022
    Table 13. Global Anti-spasmodic Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Anti-spasmodic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-spasmodic Drugs as of 2021)
    Table 15. Top Players of Anti-spasmodic Drugs in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Anti-spasmodic Drugs Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Anti-spasmodic Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Anti-spasmodic Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Anti-spasmodic Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Anti-spasmodic Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Anti-spasmodic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Anti-spasmodic Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Anti-spasmodic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Anti-spasmodic Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Anti-spasmodic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Anti-spasmodic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Anti-spasmodic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Anti-spasmodic Drugs Product
    Table 33. Pfizer Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Allergan Company Details
    Table 36. Allergan Business Overview
    Table 37. Allergan Anti-spasmodic Drugs Product
    Table 38. Allergan Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 39. Allergan Recent Development
    Table 40. Ipsen Company Details
    Table 41. Ipsen Business Overview
    Table 42. Ipsen Anti-spasmodic Drugs Product
    Table 43. Ipsen Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 44. Ipsen Recent Development
    Table 45. Teva Pharmaceuticals Company Details
    Table 46. Teva Pharmaceuticals Business Overview
    Table 47. Teva Pharmaceuticals Anti-spasmodic Drugs Product
    Table 48. Teva Pharmaceuticals Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 49. Teva Pharmaceuticals Recent Development
    Table 50. Novartis Company Details
    Table 51. Novartis Business Overview
    Table 52. Novartis Anti-spasmodic Drugs Product
    Table 53. Novartis Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 54. Novartis Recent Development
    Table 55. Johnson & Johnson Company Details
    Table 56. Johnson & Johnson Business Overview
    Table 57. Johnson & Johnson Anti-spasmodic Drugs Product
    Table 58. Johnson & Johnson Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 59. Johnson & Johnson Recent Development
    Table 60. Takeda Pharmaceutical Company Details
    Table 61. Takeda Pharmaceutical Business Overview
    Table 62. Takeda Pharmaceutical Anti-spasmodic Drugs Product
    Table 63. Takeda Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 64. Takeda Pharmaceutical Recent Development
    Table 65. Sun Pharmaceutical Industries Company Details
    Table 66. Sun Pharmaceutical Industries Business Overview
    Table 67. Sun Pharmaceutical Industries Anti-spasmodic Drugs Product
    Table 68. Sun Pharmaceutical Industries Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 69. Sun Pharmaceutical Industries Recent Development
    Table 70. Merz Pharma Company Details
    Table 71. Merz Pharma Business Overview
    Table 72. Merz Pharma Anti-spasmodic Drugs Product
    Table 73. Merz Pharma Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 74. Merz Pharma Recent Development
    Table 75. Mylan Company Details
    Table 76. Mylan Business Overview
    Table 77. Mylan Anti-spasmodic Drugs Product
    Table 78. Mylan Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 79. Mylan Recent Development
    Table 80. Fresenius Kabi Company Details
    Table 81. Fresenius Kabi Business Overview
    Table 82. Fresenius Kabi Anti-spasmodic Drugs Product
    Table 83. Fresenius Kabi Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 84. Fresenius Kabi Recent Development
    Table 85. Endo International Company Details
    Table 86. Endo International Business Overview
    Table 87. Endo International Anti-spasmodic Drugs Product
    Table 88. Endo International Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 89. Endo International Recent Development
    Table 90. Daewoong Pharmaceutical Company Details
    Table 91. Daewoong Pharmaceutical Business Overview
    Table 92. Daewoong Pharmaceutical Anti-spasmodic Drugs Product
    Table 93. Daewoong Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 94. Daewoong Pharmaceutical Recent Development
    Table 95. Acorda Therapeutics Company Details
    Table 96. Acorda Therapeutics Business Overview
    Table 97. Acorda Therapeutics Anti-spasmodic Drugs Product
    Table 98. Acorda Therapeutics Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 99. Acorda Therapeutics Recent Development
    Table 100. SteriMax Company Details
    Table 101. SteriMax Business Overview
    Table 102. SteriMax Anti-spasmodic Drugs Product
    Table 103. SteriMax Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 104. SteriMax Recent Development
    Table 105. Emcure Pharmaceuticals Company Details
    Table 106. Emcure Pharmaceuticals Business Overview
    Table 107. Emcure Pharmaceuticals Anti-spasmodic Drugs Product
    Table 108. Emcure Pharmaceuticals Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 109. Emcure Pharmaceuticals Recent Development
    Table 110. Sawai Pharmaceutical Company Details
    Table 111. Sawai Pharmaceutical Business Overview
    Table 112. Sawai Pharmaceutical Anti-spasmodic Drugs Product
    Table 113. Sawai Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 114. Sawai Pharmaceutical Recent Development
    Table 115. Orient Pharma Company Details
    Table 116. Orient Pharma Business Overview
    Table 117. Orient Pharma Anti-spasmodic Drugs Product
    Table 118. Orient Pharma Revenue in Anti-spasmodic Drugs Business (2017-2022) & (US$ Million)
    Table 119. Orient Pharma Recent Development
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-spasmodic Drugs Product Picture
    Figure 2. Global Anti-spasmodic Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti-spasmodic Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. United States Anti-spasmodic Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Anti-spasmodic Drugs Market Size 2017-2028 (US$ Million)
    Figure 6. United States Anti-spasmodic Drugs Market Share in Global 2017-2028
    Figure 7. Anti-spasmodic Drugs Report Years Considered
    Figure 8. Product Picture of Antimuscarinics
    Figure 9. Product Picture of Smooth Muscle Relaxants
    Figure 10. Global Anti-spasmodic Drugs Market Share by Type in 2022 & 2028
    Figure 11. Global Anti-spasmodic Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Anti-spasmodic Drugs Market Share by Type (2017-2028)
    Figure 13. United States Anti-spasmodic Drugs Market Share by Type in 2022 & 2028
    Figure 14. United States Anti-spasmodic Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Anti-spasmodic Drugs Market Share by Type (2017-2028)
    Figure 16. Product Picture of Offline Channel
    Figure 17. Product Picture of Online Channel
    Figure 18. Global Anti-spasmodic Drugs Market Share by Application in 2022 & 2028
    Figure 19. Global Anti-spasmodic Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global Anti-spasmodic Drugs Market Share by Application (2017-2028)
    Figure 21. United States Anti-spasmodic Drugs Market Share by Application in 2022 & 2028
    Figure 22. United States Anti-spasmodic Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States Anti-spasmodic Drugs Market Share by Application (2017-2028)
    Figure 24. North America Anti-spasmodic Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. U.S. Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe Anti-spasmodic Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Anti-spasmodic Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Taiwan Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Philippines Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Anti-spasmodic Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Anti-spasmodic Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. UAE Anti-spasmodic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Pfizer Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 53. Allergan Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 54. Ipsen Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 55. Teva Pharmaceuticals Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 56. Novartis Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 58. Takeda Pharmaceutical Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 59. Sun Pharmaceutical Industries Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 60. Merz Pharma Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 61. Mylan Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 62. Fresenius Kabi Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 63. Endo International Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 64. Daewoong Pharmaceutical Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 65. Acorda Therapeutics Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 66. SteriMax Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 67. Emcure Pharmaceuticals Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 68. Sawai Pharmaceutical Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 69. Orient Pharma Revenue Growth Rate in Anti-spasmodic Drugs Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed